Form 4: Nevro Corp Director Michael F. DeMane Reports Stock Acquisition

Director Michael F. DeMane reports acquisition of Nevro Corp stock through vested restricted stock and holdings in various trusts.

Summary

• Michael F. DeMane, a director of Nevro Corp, filed a Form 4 detailing changes in beneficial ownership.
• On September 30, 2024, DeMane acquired 4,695 shares of common stock as fully vested restricted stock, representing quarterly retainer fees received in lieu of cash.
• Following the transaction, DeMane directly owns 54,807 shares, including 19,169 restricted stock units.
• DeMane also indirectly owns shares through several trusts: 164,344 shares via the Michael F. DeMane 2012 Irrevocable Trust, 219,145 shares via the Michael F. DeMane 2017 Family SLAT Trust, and 58,266 shares via the Michael F. DeMane Revocable Trust.
• The report was signed by Kashif Rashid, as Attorney-in-Fact for Michael F. DeMane, on October 2, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it's a standard disclosure of stock acquisition by a director. The acquisition itself can be seen as mildly positive, but the document is primarily informational.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders and their holdings.

Stakeholder Impact

• The disclosure provides transparency to shareholders regarding the stock ownership of a company director.

Key Dates